enterprise

Moderna Inc Shares Close the Day 20.6% Higher – Daily Wrap – Nasdaq


Moderna Inc (MRNA) shares closed today 20.6% higher than it did at the end of yesterday. The stock is currently up 215.5% year-to-date, up 201.9% over the past 12 months, and up 1672.2% over the past five years. Today, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 2.2%.

Trading Activity

  • Shares traded as high as $350.15 and as low as $258.09 this week.
  • Shares closed 33.7% below its 52-week high and 221.1% above its 52-week low.
  • Trading volume this week was 66.2% lower than the 10-day average and 64.6% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company’s share price beats the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company’s share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and beats it on a 5 year basis

Per Group Comparative Performance

  • The company’s stock price performance year-to-date beats the peer average by -23420.1%
  • The company’s stock price performance over the past 12 months beats the peer average by 2054.9%
  • The company’s price-to-earnings ratio, which relates a company’s share price to its earnings per share, is 377.0% higher than the average peer.

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.